Mohamed Adel Said (Mohamed A Said)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Molecular Docking

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Abdou K Allayeh, Aliaa H El-Boghdady, Mohamed Adel Said, Mahmoud G A Saleh, Mohammed T Abdel-Aal, Mohamed G Abouelenein
Discovery of Pyrano[2,3- c ]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesis, In Silico, In Vitro, and ADME Studies. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Soha Osama Mahmoud Hassanin, Amany Mohammed Mohmmed Hegab, Reham Hassan Mekky, Mohamed Adel Said, Mona G Khalil, Alaaeldin Ahmed Hamza, Amr Amin
Combining In Vitro, In Vivo, and Network Pharmacology Assays to Identify Targets and Molecular Mechanisms of Spirulina-Derived Biomolecules against Breast Cancer. Marine drugs 22 (7) (2024)
Abdou K Allayeh, Aliaa H El-Boghdady, Mohamed Adel Said, Mahmoud G A Saleh, Mohammed T Abdel-Aal, Mohamed G Abouelenein
Discovery of Pyrano[2,3- c ]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesis, In Silico, In Vitro, and ADME Studies. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Soha Osama Mahmoud Hassanin, Amany Mohammed Mohmmed Hegab, Reham Hassan Mekky, Mohamed Adel Said, Mona G Khalil, Alaaeldin Ahmed Hamza, Amr Amin
Combining In Vitro, In Vivo, and Network Pharmacology Assays to Identify Targets and Molecular Mechanisms of Spirulina-Derived Biomolecules against Breast Cancer. Marine drugs 22 (7) (2024)
Soha Osama Mahmoud Hassanin, Amany Mohammed Mohmmed Hegab, Reham Hassan Mekky, Mohamed Adel Said, Mona G Khalil, Alaaeldin Ahmed Hamza, Amr Amin
Combining In Vitro, In Vivo, and Network Pharmacology Assays to Identify Targets and Molecular Mechanisms of Spirulina-Derived Biomolecules against Breast Cancer. Marine drugs 22 (7) (2024)
Mohamed A Abdelrahman, Hadia Almahli, Tarfah Al-Warhi, Taghreed A Majrashi, Marwa M Abdel-Aziz, Wagdy M Eldehna, Mohamed Adel Said
Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-Resistant Mycobacterium tuberculosis . Molecules (Basel, Switzerland) 27 (24) (2022)
Mohamed Adel Said, Amgad Albohy, Mohamed A Abdelrahman, Hany S Ibarhim
Remdesivir analog as SARS-CoV-2 polymerase inhibitor: virtual screening of a database generated by scaffold replacement. RSC advances 12 (35) (2022)
Tarfah Al-Warhi, Ahmed M El Kerdawy, Mohamed Adel Said, Amgad Albohy, Zainab M Elsayed, Nada Aljaeed, Eslam B Elkaeed, Wagdy M Eldehna, Hatem A Abdel-Aziz, Miral A Abdelmoaz
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights. Drug design, development and therapy 16 (2022)
Mohamed A Abdelrahman, Hadia Almahli, Tarfah Al-Warhi, Taghreed A Majrashi, Marwa M Abdel-Aziz, Wagdy M Eldehna, Mohamed Adel Said
Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-Resistant Mycobacterium tuberculosis . Molecules (Basel, Switzerland) 27 (24) (2022)
Mohamed A Abdelrahman, Hadia Almahli, Tarfah Al-Warhi, Taghreed A Majrashi, Marwa M Abdel-Aziz, Wagdy M Eldehna, Mohamed Adel Said
Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-Resistant Mycobacterium tuberculosis . Molecules (Basel, Switzerland) 27 (24) (2022)
Mohamed A Abdelrahman, Hadia Almahli, Tarfah Al-Warhi, Taghreed A Majrashi, Marwa M Abdel-Aziz, Wagdy M Eldehna, Mohamed Adel Said
Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-Resistant Mycobacterium tuberculosis . Molecules (Basel, Switzerland) 27 (24) (2022)